Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C

Chronic infection with the hepatitis C virus (HCV) remains a major health problem affecting approximately 58 million people worldwide. In the era of interferon (IFN)-based regimens, patients particularly infected with genotypes 1 and 4 achieved a low response rate. The implementation of direct-actin...

Descripción completa

Detalles Bibliográficos
Autores principales: Brzdęk, Michał, Zarębska-Michaluk, Dorota, Invernizzi, Federica, Cilla, Marta, Dobrowolska, Krystyna, Flisiak, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950869/
https://www.ncbi.nlm.nih.gov/pubmed/36844142
http://dx.doi.org/10.3748/wjg.v29.i6.949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950869/
https://www.ncbi.nlm.nih.gov/pubmed/36844142
http://dx.doi.org/10.3748/wjg.v29.i6.949

Ejemplares similares